AlfredSamuelCallahanIIIMD

PubMed

• 1 citations
  Reply: Hemorrhagic Stroke, All-Cause Death, and Intensive LDL-C Lowering: Evidence From SPARCL and Beyond
  Michael Szarek, Pierre Amarenco, Alfred Callahan, Larry B. Goldstein, Henrik Sillesen, K. Michael A. Welch, Sparcl Committees, Investigators> ;Journal of the American College of Cardiology. 2020 Aug 18
• 22 citations
  Atorvastatin Reduces First and Subsequent Vascular Events Across Vascular Territories: The SPARCL Trial
  Michael Szarek, Pierre Amarenco, Alfred Callahan, David A. DeMicco, Rana Fayyad, Larry B. Goldstein, Rachel Laskey, Henrik Sillesen, K. Michael A. Welch, Sparcl Commit...> ;Journal of the American College of Cardiology. 2020 May 5
• 26 citations
  Effect of High-Dose Atorvastatin on Renal Function in Subjects With Stroke or Transient Ischemic Attack in the SPARCL Trial
  Pierre Amarenco, Alfred Callahan, Vito M. Campese, Larry B. Goldstein, Michael G. Hennerici, Michael Messig, Henrik Sillesen, K. Michael A. Welch, Daniel J. Wilson, Ju...> ;Stroke. 2014 Oct 1
• 6 citations
  Prediction of Major Vascular Events after Stroke: The Stroke Prevention by Aggressive Reduction in Cholesterol Levels Trial
  Bruce Ovbiagele, Larry B. Goldstein, Pierre Amarenco, Michael Messig, Henrik Sillesen, Alfred Callahan, Michael G. Hennerici, Justin A. Zivin, K. Michael A. Welch> ;Journal of Stroke and Cerebrovascular Diseases. 2014 Apr 1
• Maximum carotid artery wall thickness and risk factors in a young primary prevention population
  Alfred Callahan, Michael Szarek, John W. Patton, Anne-Sophie Sillesen, Abrill Jones, Keith Churchwell, H Douglas Holliday> ;Brain and Behavior. 2012 Sep 1
• 77 citations
  Risk of Stroke and Cardiovascular Events After Ischemic Stroke or Transient Ischemic Attack in Patients With Type 2 Diabetes or Metabolic Syndrome: Secondary Analysis ...
  Alfred Callahan, Pierre Amarenco, Larry B. Goldstein, Henrik Sillesen, Mike Messig, Gregory P. Samsa, Irfan Altafullah, Lucy Y Ledbetter, Mary Joan MacLeod, Russell S....> ;Archives of Neurology. 2011 Oct 1
• 38 citations
  Coronary Heart Disease Risk in Patients With Stroke or Transient Ischemic Attack and No Known Coronary Heart Disease Findings From the Stroke Prevention by Aggressive ...
  Pierre Amarenco, Larry B. Goldstein, Henrik Sillesen, Oscar R. Benavente, Richard M. Zweifler, Alfred Callahan, Michael G. Hennerici, Justin A. Zivin, K. Michael A. Welch> ;Stroke. 2010 Mar 1
• 98 citations
  Statin Treatment and Stroke Outcome in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Trial
  Larry B. Goldstein, Pierre Amarenco, Justin A. Zivin, Michael Messig, Irfan Altafullah, Alfred Callahan, Michael G. Hennerici, Mary Joan MacLeod, Henrik Sillesen, Rich...> ;Stroke. 2009 Nov 1
• 51 citations
  Relative and Cumulative Effects of Lipid and Blood Pressure Control in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels Trial
  Pierre Amarenco, Larry B. Goldstein, Michael Messig, Blair J. O'Neill, Alfred Callahan, Henrik Sillesen, Michael G. Hennerici, Justin A. Zivin, K M Welch> ;Stroke. 2009 Jul 1
• 76 citations
  Baseline blood pressure, low- and high-density lipoproteins, and triglycerides and the risk of vascular events in the Stroke Prevention by Aggressive Reduction in Chol...
  Pierre Amarenco, Larry B. Goldstein, Alfred Callahan, Henrik Sillesen, Michael G. Hennerici, Blair J. O'Neill, Amy E. Rudolph, Lisa Simunovic, Justin A. Zivin, K M Welch> ;Atherosclerosis. 2009 Jun 1
• 164 citations
  Results of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Trial by Stroke Subtypes
  Pierre Amarenco, Oscar Benavente, Larry B. Goldstein, Alfred Callahan, Henrik Sillesen, Michael G. Hennerici, Steve Gilbert, Amy E. Rudolph, Lisa Simunovic, Justin A. ...> ;Stroke. 2009 Apr 1
• 15 citations
  Effect of atorvastatin in elderly patients with a recent stroke or transient ischemic attack.
  S Chaturvedi, J Zivin, A Breazna, P Amarenco, A Callahan, L B Goldstein, M Hennerici, H Sillesen, A Rudolph, M A Welch> ;Neurology. 2009 Feb 24
• 188 citations
  Atorvastatin Reduces the Risk of Cardiovascular Events in Patients With Carotid Atherosclerosis: A Secondary Analysis of the Stroke Prevention by Aggressive Reduction ...
  Henrik Sillesen, Pierre Amarenco, Michael G. Hennerici, Alfred Callahan, Larry B. Goldstein, Justin A. Zivin, Michael Messig, K. Michael A. Welch> ;Stroke. 2008 Dec 1
• 65 citations
  Relative Effects of Statin Therapy on Stroke and Cardiovascular Events in Men and Women. Secondary Analysis of the Stroke Prevention by Aggressive Reduction in Cholest...
  Larry B. Goldstein, Pierre Amarenco, Marian P. LaMonte, Steven Gilbert, Michael Messig, Alfred Callahan, Michael G. Hennerici, Henrik Sillesen, K. Michael A. Welch> ;Stroke. 2008 Sep 1
• Hemorrhagic stroke in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels study.
  Goldstein LB, Amarenco P, Szarek M, Callahan A, Hennerici M, Sillesen H, Zivin JA, Welch KMA> ;Neurology. 2008-06-10
• 220 citations
  Effects of Intense Low-Density Lipoprotein Cholesterol Reduction in Patients With Stroke or Transient Ischemic Attack The Stroke Prevention by Aggressive Reduction in ...
  Pierre Amarenco, Larry B. Goldstein, Michael Szarek, Henrik Sillesen, Amy E. Rudolph, Alfred Callahan, Michael G. Hennerici, Lisa Simunovic, Justin A. Zivin, K. Michae...> ;Stroke. 2007 Dec 1
• High-dose atorvastatin after stroke or transient ischemic attack.
  Amarenco P, Bogousslavsky J, Callahan A, Goldstein LB, Hennerici M, Rudolph AE, Sillesen H, Simunovic L, Szarek M, Welch KMA, Zivin JA> ;N. Engl. J. Med.. 2006-08-10
• 12 citations
  Long-Term Therapy to Prevent Stroke
  Howard S. Kirshner, José Biller, Alfred S. Callahan> ;The Journal of the American Board of Family Practice. 2005 Nov 1
• 13 citations
  Statins for secondary stroke prevention in patients without known coronary heart disease: the jury is still out.
  Larry B. Goldstein, Pierre Amarenco, Julien Bogousslavsky, Alfred Callahan, M.G. Hennerici, K M Welch, Justin A. Zivin, Henrik Sillesen> ;Cerebrovascular Diseases. 2004 Jan 1
• 55 citations
  Factors Influencing Outcome and Treatment Effect in PROACT II
  Lawrence R. Wechsler, Robin S. Roberts, Anthony J. Furlan, Randall T. Higashida, William P. Dillon, Heidi C. Roberts, Howard A. Rowley, L. Creed Pettigrew, Alfred Call...> ;Stroke. 2003 May 1
• 136 citations
  Design and baseline characteristics of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Study
  Henrik Sillesen, Gregory W. Albers, Irfan Altafullah, Oscar Benavente, Diane S. Book, Joseph P. Broderick, Christopher Calder, Alfred Callahan, Walter Carlini, Seemant...> ;Cerebrovascular Diseases. 2003 Jan 1
• 30 citations
  Cerebrovascular disease and statins: a potential addition to the therapeutic armamentarium for stroke prevention.
  Alfred Callahan> ;The American Journal of Cardiology. 2001 Oct 11
• Possible short-term amelioration of basilar plaque by high-dose atorvastatin: use of reductase inhibitors for intracranial plaque stabilization.
  Callahan AS, Berger BL, Beuter MJ, Devlin TG> ;J Neuroimaging. 2001-04-01
• 6 citations
  Basilar artery endoprosthesis placement: rescue therapy for recurrent thrombosis.
  Alfred S. Callahan, Brian L. Berger> ;Journal of Neuroimaging. 2000 Jan 1
• Balloon angioplasty of intracranial arteries for stroke prevention.
  Callahan AS, Berger BL> ;J Neuroimaging. 1997-10-01
• Join now to see all

Lectures

• Neurology & Psychiatry Challenges in Primary Care - CME Getaways New Orleans 
  CME Getaways, New Orleans, Louisiana - 9/21/2012